Free Trial

Theratechnologies (THTX) Competitors

Theratechnologies logo
$2.59 +0.04 (+1.57%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$2.55 -0.04 (-1.54%)
As of 08:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

THTX vs. URGN, ARVN, TSHA, CGEM, ETON, ALT, SANA, MGTX, MAZE, and SIGA

Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include UroGen Pharma (URGN), Arvinas (ARVN), Taysha Gene Therapies (TSHA), Cullinan Therapeutics (CGEM), Eton Pharmaceuticals (ETON), Altimmune (ALT), Sana Biotechnology (SANA), MeiraGTx (MGTX), Maze Therapeutics (MAZE), and SIGA Technologies (SIGA). These companies are all part of the "pharmaceutical products" industry.

Theratechnologies vs.

UroGen Pharma (NASDAQ:URGN) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends.

UroGen Pharma received 348 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 74.17% of users gave UroGen Pharma an outperform vote while only 54.39% of users gave Theratechnologies an outperform vote.

CompanyUnderperformOutperform
UroGen PharmaOutperform Votes
379
74.17%
Underperform Votes
132
25.83%
TheratechnologiesOutperform Votes
31
54.39%
Underperform Votes
26
45.61%

UroGen Pharma presently has a consensus target price of $31.00, indicating a potential upside of 659.80%. Given UroGen Pharma's higher possible upside, analysts clearly believe UroGen Pharma is more favorable than Theratechnologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UroGen Pharma
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88
Theratechnologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00

Theratechnologies has a net margin of -3.75% compared to UroGen Pharma's net margin of -129.11%.

Company Net Margins Return on Equity Return on Assets
UroGen Pharma-129.11% N/A -47.94%
Theratechnologies -3.75%N/A -4.31%

91.3% of UroGen Pharma shares are held by institutional investors. 5.1% of UroGen Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, UroGen Pharma had 26 more articles in the media than Theratechnologies. MarketBeat recorded 26 mentions for UroGen Pharma and 0 mentions for Theratechnologies. UroGen Pharma's average media sentiment score of 0.20 beat Theratechnologies' score of 0.00 indicating that UroGen Pharma is being referred to more favorably in the media.

Company Overall Sentiment
UroGen Pharma Neutral
Theratechnologies Neutral

Theratechnologies has lower revenue, but higher earnings than UroGen Pharma. Theratechnologies is trading at a lower price-to-earnings ratio than UroGen Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UroGen Pharma$91.87M2.05-$102.24M-$3.18-1.28
Theratechnologies$88.67M1.34-$23.96M-$0.08-32.38

UroGen Pharma has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.

Summary

UroGen Pharma beats Theratechnologies on 12 of the 18 factors compared between the two stocks.

Get Theratechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THTX vs. The Competition

MetricTheratechnologiesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$119.09M$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.10%
P/E Ratio-25.909.0626.7719.70
Price / Sales1.34259.83393.27122.35
Price / CashN/A65.8538.2534.62
Price / Book-5.766.456.774.50
Net Income-$23.96M$143.98M$3.23B$248.22M
7 Day Performance-0.77%0.38%0.43%-0.80%
1 Month Performance-4.07%2.14%9.07%11.52%
1 Year Performance108.87%-0.33%18.57%8.99%

Theratechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THTX
Theratechnologies
N/A$2.59
+1.6%
N/A+103.9%$119.09M$88.67M-25.90140
URGN
UroGen Pharma
4.1018 of 5 stars
$11.14
+7.3%
$32.86
+194.9%
-69.3%$478.59M$90.40M-3.54200Trending News
Analyst Downgrade
ARVN
Arvinas
3.619 of 5 stars
$6.52
-1.4%
$20.91
+220.7%
-82.0%$475.90M$426.90M-2.35420
TSHA
Taysha Gene Therapies
2.7203 of 5 stars
$2.32
+8.9%
$6.63
+185.6%
-4.0%$475.73M$8.33M3.68180Analyst Revision
Gap Up
CGEM
Cullinan Therapeutics
2.5406 of 5 stars
$7.91
+4.9%
$32.00
+304.6%
-65.9%$466.81MN/A-2.7930Positive News
ETON
Eton Pharmaceuticals
2.3797 of 5 stars
$17.35
+3.3%
$27.67
+59.5%
+453.3%$465.29M$39.01M-78.8620High Trading Volume
ALT
Altimmune
2.4714 of 5 stars
$6.01
+7.5%
$20.20
+236.1%
-26.9%$462.85M$20,000.00-3.8850Analyst Upgrade
SANA
Sana Biotechnology
2.4234 of 5 stars
$2.00
+9.9%
$10.80
+440.0%
-75.8%$450.95MN/A-1.43380Gap Down
High Trading Volume
MGTX
MeiraGTx
4.5696 of 5 stars
$5.62
+3.7%
$24.50
+335.9%
-10.6%$449.33M$33.28M-4.64300Analyst Downgrade
MAZE
Maze Therapeutics
N/A$10.13
+5.3%
$25.67
+153.4%
N/A$443.65M$167.50M0.00121
SIGA
SIGA Technologies
1.1496 of 5 stars
$5.94
+4.9%
N/A-21.9%$424.36M$138.72M4.9540Positive News

Related Companies and Tools


This page (NASDAQ:THTX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners